Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02189343 |
| Title | Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed-and-Refractory Multiple Myeloma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Acetylon Pharmaceuticals Incorporated |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UT Southwestern Medical Center Simmons Comprehensive Cancer Center | Dallas | Texas | 75390-8852 | United States | Details | |
| CTRC at The UT Health Science Center at San Antonio | San Antonio | Texas | 78229 | United States | Details | |
| University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details |